ACRS

ACRS

Aclaris Therapeutics Inc. Common Stock

$1.535+0.000 (0.000%)

即時價格

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.535

最高

$1.535

最低

$1.535

交易量

0.61M

公司基本面

交易統計

相關新聞

GlobeNewswire

Aclaris Therapeutics to Participate in Two June Healthcare Conferences

WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today

查看更多
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Analyst Upgrades

Wedbush Initiates Coverage On Aclaris Therapeutics with Outperform Rating, Announces Price Target of $8

Wedbush analyst Martin Fan initiates coverage on Aclaris Therapeutics with a Outperform rating and announces Price Target of $8.

查看更多
Wedbush Initiates Coverage On Aclaris Therapeutics with Outperform Rating, Announces Price Target of $8
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Aclaris Therapeutics, Lowers Price Target to $16

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aclaris Therapeutics with a Buy and lowers the price target from $20 to $16.

查看更多
HC Wainwright & Co. Maintains Buy on Aclaris Therapeutics, Lowers Price Target to $16
GlobeNewswire

Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

- Multiple Catalysts in Immuno-Inflammatory Indications Anticipated in 2025 and 2026 - - Expected Cash Runway Extended Through the First Half of 2028 - - Phase 2 Results Received to Date from Chinese Partner CTTQ

查看更多
Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update